Amicus Therapeutics, Inc. (FOLD)
14.28
-0.07
(-0.49%)
USD |
NASDAQ |
Jan 22, 11:58
Amicus Therapeutics Research and Development Expense (TTM): 142.29M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 682.06M |
| CorMedix, Inc. | 12.46M |
| Krystal Biotech, Inc. | 55.37M |
| ANI Pharmaceuticals, Inc. | 56.05M |
| Ekso Bionics Holdings, Inc. | 3.235M |